Delivery Order SPE2DB20D2014-SPE2DB24FC41B

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is a $5,898.95 firm-fixed-price delivery order for the supply of CELLCEPT 500 MG TABLET 100S. The award has an ultimate completion date of February 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,224.16 firm fixed-price delivery order is for the supply of 4,567,390,794 units of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,325.88 firm fixed price delivery order is for the supply of 4,565,031,462 units of CellCept 500 mg tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,342.11 firm fixed-price delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, with a ceiling value of $8,568.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 4, 2025. The contract provides for the delivery of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 17, 2025. The $5,441.20 firm fixed-price delivery order is for the supply of CELLCEPT 500 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of March 18, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,805.39 firm fixed-price delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,931.01 firm fixed-price delivery order is for the supply of 4,566,481,699 units of CELLCEPT 500 MG TABLET 100S, with an ultimate completion date of November 20, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of CellCept 500 mg tablets to the Defense Logistics Agency (DLA). The $2,325.88 firm-fixed-price delivery order is placed under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $25,351.33, is for the delivery of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product, with a period of performance through August 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts and...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC41B
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with a Ceiling Value of $9,218.84. The contract is for the delivery of CELLCEPT 500 MG TABLET 100S and is a Firm Fixed Price contract type. The ultimate completion date for this order is July 9, 2024.

Amerisourcebergen Drug Corp holds a larger IDC with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract does not have a set-aside designation.

Generated 10/7/24, 10:48 AM